Paragon Private Wealth Management’s Boston Scientific BSX Stock Holding History

Paragon Private Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$500K	Sell	11,711 -3,736	-24%	-$203K	0.13%	149
2026 Q1	$969K	Sell	15,447 -503	-3%	-$40.2K	0.3%	92
2025 Q4	$1.52M	Buy	15,950 +185	+1%	+$18.1K	0.47%	53
2025 Q3	$1.54M	Buy	15,765 +3,986	+34%	+$413K	0.5%	53
2025 Q2	$1.27M	Buy	11,779 +1,715	+17%	+$174K	0.5%	54
2025 Q1	$1.02M	Buy	10,064 +1,917	+24%	+$193K	0.47%	65
2024 Q4	$728K	Buy	8,147 +1,529	+23%	+$135K	0.34%	82
2024 Q3	$555K	Buy	6,618 +1,325	+25%	+$104K	0.27%	97
2024 Q2	$408K	Buy	+5,293	New	+$387K	0.23%	105

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paragon Private Wealth Management's BSX Position: Q2 2026 in Review

Paragon Private Wealth Management reduced its Boston Scientific (BSX) stake by 24% in Q2 2026, selling an estimated $203K and leaving 11,711 shares worth $500K. The position accounts for 0.13% of the portfolio, ranked #149.

Paragon Private Wealth Management first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.54M in Q3 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Paragon Private Wealth Management held 11,711 shares of Boston Scientific worth $500K as of Q2 2026.
Paragon Private Wealth Management sold 3,736 Boston Scientific shares in Q2 2026, an estimated $203K.
Boston Scientific made up 0.13% of Paragon Private Wealth Management's portfolio in Q2 2026, its #149 holding.
Paragon Private Wealth Management first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
Paragon Private Wealth Management's Boston Scientific position peaked at $1.54M in Q3 2025.
1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Paragon Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.